The University of Chicago Header Logo

Connection

Gladell Paner to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Gladell Paner has written about Biomarkers, Tumor.
Gladell Paner
Connection Strength
3.603
Biomarkers, Tumor
  1. Oncocytic Tumors in the Kidney: A Trifocal Review - Integrated Pathological, Cytopathological, and Molecular Perspectives (Part 1). Acta Cytol. 2025; 69(5):453-461.
    View in: PubMed
    Score: 0.493
  2. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. Hum Pathol. 2020 12; 106:54-61.
    View in: PubMed
    Score: 0.360
  3. Potential biomarkers and risk assessment models to enhance the tumor-node-metastasis (TNM) staging classification of urologic cancers. Expert Rev Mol Diagn. 2020 09; 20(9):921-932.
    View in: PubMed
    Score: 0.359
  4. Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer. Cells. 2020 09 17; 9(9).
    View in: PubMed
    Score: 0.359
  5. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol. 2014 Jul; 45(7):1473-82.
    View in: PubMed
    Score: 0.229
  6. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol. 2011 Jun; 35(6):787-98.
    View in: PubMed
    Score: 0.188
  7. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008 Sep; 132(9):1388-96.
    View in: PubMed
    Score: 0.156
  8. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006 Jan; 30(1):13-9.
    View in: PubMed
    Score: 0.129
  9. Oncocytic Tumors in the Kidney: A Tri-Focal Review - Integrated Pathological, Cytopathological, and Molecular Perspectives, Part 2. Acta Cytol. 2025; 69(5):462-473.
    View in: PubMed
    Score: 0.123
  10. Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes. Virchows Arch. 2024 Sep; 485(3):535-546.
    View in: PubMed
    Score: 0.117
  11. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration. Hum Pathol. 2022 03; 121:11-18.
    View in: PubMed
    Score: 0.098
  12. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra. Am J Surg Pathol. 2021 04 01; 45(4):543-549.
    View in: PubMed
    Score: 0.093
  13. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma. Int J Surg Pathol. 2020 Feb; 28(1):51-59.
    View in: PubMed
    Score: 0.084
  14. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. Am J Surg Pathol. 2018 03; 42(3):279-292.
    View in: PubMed
    Score: 0.075
  15. The New Realization About Cribriform Prostate Cancer. Adv Anat Pathol. 2018 Jan; 25(1):31-37.
    View in: PubMed
    Score: 0.074
  16. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol. 2014 Sep; 38(9):1251-9.
    View in: PubMed
    Score: 0.059
  17. Uroplakin II outperforms uroplakin III in diagnostically challenging settings. Histopathology. 2014 Jul; 65(1):132-8.
    View in: PubMed
    Score: 0.057
  18. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. Am J Surg Pathol. 2014 Jan; 38(1):111-8.
    View in: PubMed
    Score: 0.056
  19. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013 Feb; 44(2):164-72.
    View in: PubMed
    Score: 0.052
  20. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol. 2009 Feb; 33(2):241-7.
    View in: PubMed
    Score: 0.040
  21. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol. 2009 Jan; 33(1):99-105.
    View in: PubMed
    Score: 0.040
  22. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol. 2008 Jul; 32(7):1022-8.
    View in: PubMed
    Score: 0.038
  23. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg Pathol. 2007 Oct; 31(10):1528-33.
    View in: PubMed
    Score: 0.037
  24. Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch Pathol Lab Med. 2005 Oct; 129(10):1317-21.
    View in: PubMed
    Score: 0.032
  25. A retroperitoneal mass in an elderly woman. Pleomorphic rhabdomyosarcoma, classic variant, with reactive osteoclast-like giant cells. Arch Pathol Lab Med. 2005 May; 129(5):703-5.
    View in: PubMed
    Score: 0.031
  26. Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch. 2024 Nov; 485(5):829-840.
    View in: PubMed
    Score: 0.030
  27. Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature. Histopathology. 2024 Nov; 85(5):748-759.
    View in: PubMed
    Score: 0.029
  28. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma. Adv Anat Pathol. 2024 May 01; 31(3):202-205.
    View in: PubMed
    Score: 0.029
  29. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021 07 01; 28(4):196-208.
    View in: PubMed
    Score: 0.024
  30. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020 05; 44(5):673-680.
    View in: PubMed
    Score: 0.022
  31. Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol. 2014 Jul; 38(7):871-4.
    View in: PubMed
    Score: 0.015
  32. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.014
  33. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol. 2013 May; 44(5):860-6.
    View in: PubMed
    Score: 0.013
  34. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol. 2013 Jan; 63(1):16-35.
    View in: PubMed
    Score: 0.013
  35. Primary vascular tumors and tumor-like lesions of the kidney: a clinicopathologic analysis of 25 cases. Am J Surg Pathol. 2010 Jul; 34(7):942-9.
    View in: PubMed
    Score: 0.011
  36. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol. 2008 May; 15(3):127-39.
    View in: PubMed
    Score: 0.010
  37. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases. Virchows Arch. 2008 Jan; 452(1):49-55.
    View in: PubMed
    Score: 0.009
  38. A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum. Arch Pathol Lab Med. 2002 Jul; 126(7):853-5.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.